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Summary 
A role for the 0~4-integrin (OL4~ 1  or  0t.4~7) ,  has been imphcated in the recruitment of peripheral 
blood mononuclear cells  (PBMCs)  to sites of inflammation. However, the  adhesive interac- 
tions (i.e., tethering, rolling, and adhesion) mediated by the ot4-integrin have not been charac- 
terized in vivo.  The objective of this  study was  to  establish  a  model wherein postcapillary 
venules were chronically inflamed, and then use intravital microscopy to identify the adhesive 
interactions mediated by the ot4-integrin in vivo. Between 4 and 20 d after immunization with 
Mycobacterium  butyricum,  animals developed a systemic vasculitis  characterized by large increases 
in the  numbers  of rolling and adhering leukocytes within mesenteric venules. The selectins 
could only account for "50% of the leukocyte rolling whereas the remaining cells rolled ex- 
clusively via the ot4-integrin. Anti-or  4 therapy also ehminated the increase in leukocyte adhesion 
observed in this model, whereas selectin therapies and an anti-CD18 ([32-integrin)  monoclonal 
antibody  (mAb)  did  not  reduce  adhesion.  A  serum  against  polymorphonuclear leukocytes 
(PMNs) was used to confirm that a significant proportion of rolling cells, and most of the ad- 
hering cells were PBMCs.  Sequential treatment with anti-PMN serum and the anti-cq mAb 
demonstrated that ot4-dependent rolling was distinct from PMN rolling populations. Initial leu- 
kocyte tethering via the ot4-integrin could not be demonstrated in this model, whereas L-selec- 
tin did support leukocyte tethering. These data suggest that the o~4-integrin can mediate both 
rolling and adhesion in the multistep recruitment of PMBCs in vivo, and these interactions oc- 
cur independently of the selectins and [32-integrins. 
T 
here is a wealth of information describing the recruit- 
ment of PMNs from the mainstream of blood to sites 
ofextravascular injury. This multistep process is initiated by 
the tethering of  PMNs to the endothehum, followed by weak 
transient adhesive interactions manifested as leukocyte roll- 
ing,  leading ultimately to firm adhesion of PMNs  to  the 
vessel wall (1-4). If an appropriate chemotactic stimulus is 
present,  firm adhesion then allows leukocytes to transmi- 
grate across the vessel wall to sites of potential injury (5, 6). 
Different mechanisms appear to mediate PMN rolling and 
adhesion; rolling is dependent on selectins expressed on en- 
dothehum (P-selectin, E-selectin) and leukocytes (L-selec- 
tin), whereas firm adhesion is dependent on the binding of 
leukocyte integrins  (CDll/CD18)  to their ligands  (inter- 
cellular adhesion molecule 1 [ICAM-1], etc.) found on en- 
dothehal cells (3, 4, 7, 8). Intravital microscopy has played a 
critical role in establishing the molecular mechanisms un- 
derlying PMN rolling and adhesion as it provides a win- 
dow for the  direct observation of PMN  behavior within 
intact postcapillary venules. However, because of a lack of 
chronic inflammatory models amenable to intravital micros- 
copy, there is very htde information regarding the adhesive 
mechanisms  that  regulate  the  influx  of other  leukocytes 
such as PBMCs into postcapillary venules. 
There is a growing body of evidence implicating an im- 
portant role for 0t4-integrin complexes (c~4131 or ot4137) in 
the recruitment of PBMCs into sites of inflammation, cl4131 
is expressed on a large proportion of PBMCs, and mediates 
adhesion of these cells to  cytokine-activated endothehum 
in vitro via the counterreceptor vascular cell adhesion mol- 
ecule  1  (VCAM-1) 1 (9-12).  In vivo studies have demon- 
strated  that  nlindium-labeled  rat  lymphocyte subpopula- 
tions migrate via ot4-integrins  to inflammatory sites in the 
skin in response to cytokines or delayed-type hypersensitiv- 
ity reactions (13,  14),  and to arthritic joints of rats  treated 
with complete Freund's adjuvant  (14).  Numerous in vivo 
and  in  vitro  studies  have  demonstrated  that  dual  anti-~x  4 
and anti-CD18 therapy provided an additive inhibition of 
PBMC infiltration, raising the possibility that the two ad- 
hesion  molecules function in  tandem for optimal move- 
1Abbreviations used in this paper: fMLP, N-formyl-met-leu-phe;  VCAM-1, 
vascular cell adhesion molecule  1. 
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Volume 183 May 1996 1995-2006 ment of PBMC into tissues (11, 15-17). Assuming that PB- 
MCs, like PMNs,  infiltrate tissues via a  multi-step process 
that may engage numerous adhesive mechanisms, an obvious 
shortcoming of the  aforementioned studies is the inability 
to determine at which point in the cascade (tethering, roll- 
ing, or adhesion) the Ix4-integrin intervenes. This may be par- 
ticularly important in that in vitro studies using flow condi- 
tions raise the possibility of an unexpected versatility for the 
ci4-integrins; PBMCs have been shown to tether, roll, and 
adhere via 0q-integrins to isolated VCAM-1  or VCAM-1- 
transfected  L  cells  (18-20).  Increasing  the  complexity  of 
the substratum to cytokine-treated endothelium gave more 
ambiguous results; antibodies against the cl4-integrins inhib- 
ited firm adhesion of PBMCs but failed to affect the initial 
tethering and/or rolling interaction in some but not all stud- 
ies (19-21).  These somewhat discrepant observations make 
it difficult to extend these in vitro studies to the in vivo set- 
ting wherein the c%-integrin may or may not function as a 
tethering, rolling, and/or adhesion molecule. 
Clearly, there is a need to assess  the role of ci4-integrins 
in postcapillary venules  at potential sites of inflammation. 
Since  acutely  inflamed  vessels  support  primarily  PMN- 
endothelial cell interactions  (22,  23),  the  visuahzation  of 
oq-dependent interactions (tethering, rolling, and adhesion) 
has not been documented using existing models ofintravital 
microscopy. Therefore, the first objective was to estabhsh a 
model  wherein  postcapillary  vessels  would  support  of  4- 
dependent interactions, and then to determine whether this 
adhesion molecule contributes to leukocyte tethering, roll- 
ing, and/or adhesion in vivo. In this study, we describe the 
development  of a  systemic vasculitis 4-20  d  after animals 
are immunized with complete Freund's adjuvant. This con- 
dition is hallmarked by a tremendous increase in the num- 
ber  of tethering,  rolling,  and  adhering  leukocytes within 
mesenteric postcapillary venules. Approximately 50% of these 
cells were PBMCs,  and interacted with the venular endo- 
thelium independently of the  selectins or the  [32-integrin. 
Antibody studies revealed that the o~4-integrin mediated at 
least two pathways in the multi-step recruitment of PBMCs 
in vivo; both rolling and adhesion (but not tethering) were 
mediated by the  ot4-integrin,  and  these  interactions  could 
occur  independently  of selectins  or  the  [32-integrins,  re- 
spectively. 
Materials  and Methods 
Adjuvant Immunization.  Under light anesthetic (diethyl ether; 
BDH  Inc.,  Toronto,  ON,  Canada),  male Sprague-Dawley rats 
(175-275 g) were injected subcutaneously at the base of the tail 
with a solution of heat killed Mycobacterium butyricum in Freund's 
mineral oil adjuvant (0.75  mg M.  butyricum in 0.1  ml adjuvant; 
both from Difco Laboratories Inc., Detroit, MI). This protocol has 
been used as a model of arthritis in other laboratories and is de- 
scribed in detail elsewhere (14,  16, 24).  The animals were moni- 
tored closely and weighed at 4-d intervals. Preliminary experiments 
using intravital microscopy (described below) revealed a tremen- 
dous  increase  in  leukocyte  trafficking  through  postcapillary 
venules of the mesenteric connective tissue at 4, 8,  12, and 20 d 
after immunization. One group of animals was immunized with 
0.1 ml of mineral oil without M. butyricum. Leukocyte trafficking in 
this group was indistinguishable from untreated animals, therefore 
immunized animals were compared directly with untreated controls. 
Intravital Microscopy.  Rats were maintained on a purified lab- 
oratory diet and fasted for 18-24 h before surgery. Animals were 
anesthetized with an intraperitoneal injection of sodium pento- 
barbitol (65  mg/kg body weight).  The  right carotid artery and 
jugular vein were cannulated to measure systemic arterial blood 
pressure (pressure  transducer model P23XL;  Viggo-Spectramed, 
Oxnard,  CA;  and  model 7  physiologic recorder;  Grass  Instru- 
ments  Co.,  Quincy,  MA)  and administer drugs and antibodies, 
respectively. After laparotomy, rats were placed in a supine posi- 
tion on an adjustable Plexiglass  TM  microscope stage and a segment 
of the mid-jejunum was  exteriorized and prepared for intravital 
microscopy. Briefly, the mesentery was placed over an optically 
clear viewing pedestal and exposed tissues were covered with sa- 
line-soaked gauze to minimize dehydration. The temperature of 
the pedestal was maintained at 37~  with a constant temperature 
water circulator (Haake Fisons, Karlsruhe, Germany) and the rats 
were kept at 37~  using an infrared heat lamp. The exposed mes- 
entery was suffused with warmed bicarbonate-buffered saline (pH 
7.4)  using a peristaltic pump  (Minipuls3; Villiers Le Bel, Gilson, 
France), while excess fluid was removed via a suction pump. This 
preparation has been used extensively by us and others to study 
leukocyte-endothelial cell interactions within the mesenteric cir- 
culation (1, 25-28). 
The mesenteric preparation was observed through an intravital 
microscope (Optiphot-2; Nikon Inc., Mississauga,  Canada) with 
a  ￿  objective lens (Wetzlar L25/0.35;  E. Leitz Inc., Munich, 
Germany) and a ￿  10 eyepiece. A video camera (model 5100 HS; 
Panasonic,  Osaka, Japan) mounted on the microscope projected the 
image onto a color monitor (model PVM 2030; Sony, Tokyo, Ja- 
pan), and the images were recorded using a videocassette recorder 
(model AG-1790; Panasonic, Osaka, Japan) for subsequent play- 
back analysis. The final magnification of the image on the monitor 
was  ￿  t800.  Single unbranched mesenteric venules (25-50  ~m 
in diameter) were selected for study. The same section ofvenule 
was observed throughout the experiment to control for variations 
between different regions. Venular diameter (Dv) was measured 
on-line using a video caliper (Microcirculation Research Institute, 
Texas  A&M University,  College Station,  TX).  Centerline  red 
blood cell velocity (Vrbc) was also measured onqine using an op- 
tical Doppler velocimeter (Microcirculation Research  Institute, 
Texas A&M University). Venular blood flow was calculated from 
the product of cross-sectional area and mean red blood cell veloc- 
ity (Vmean =  Vrbc/1.6) assuming cylindrical geometry. Venular 
wall shear rate (~) was calculated based on the Newtonian defini- 
tion: "y =  8(Vmean/Dv),  and venular wall shear stress was 7  ￿ 
blood viscosity (lq), where "q was assumed to be 0.025 poise (29). 
The  number  of rolling and  adherent  leukocytes was  deter- 
mined off-hne during video playback analysis.  Leukocytes were 
considered adherent to the venular endothelium if they remained 
stationary for a period of time equal to or exceeding 30 s. Rolling 
leukocytes were defined as those white blood cells that moved at a 
velocity less than that oferythrocytes within a given vessel. The flux 
of rolling leukoeytes was  determined  as  the  number  of white 
blood cells that rolled past a fixed point in the venule during a l-rain 
interval using frame-by-frame analysis. Leukocyte rolling velocity 
was  calculated from the time required for a given leukocyte to 
travel a fixed distance along the length of the venule. Leukocyte 
tethering was measured as the number of new endothelial inter- 
actions that were initiated within a given segment of venule dur- 
ing a l-rain time interval. 
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25-50 ~m in diameter, the image was recorded for 5 rain. Addi- 
tional 5-min recordings were made at 15-rain intervals over a 60- 
rain period and revealed little or no change in hemodynamic pa- 
rameters  or  leukocyte  kinetics  throughout  the  experiment. 
Therefore, antiadhesion molecule therapies were administered af- 
ter two  baseline recordings  (at  the  20-min time point)  so that 
each animal served as its own control. Initially, we examined leu- 
kocyte trafficking through mesenteric postcapillary venules at 4, 8, 
12, or 20 d after immunization. No animals were allowed to sur- 
vive past 20  d  due  to  the  development of severe arthritis and 
other systemic complications. Leukocyte kinetics appeared to be 
identical at each of the days after treatment with M. butyricum, and 
therefore we undertook to examine the adhesive mechanisms in- 
volved at day 4 to avoid unnecessary discomfort related to the de- 
velopment of arthritis between days 8 and 20. 
Initially, we characterized the importance of L- and P-selectin 
in the increased leukocyte influx. The  anti-P-selectin antibody, 
PB1.3  (30)  (Cytel Corp., San Diego, CA) was administered at 
2 mg/kg i.v. at 20 rain. We have previously demonstrated that this 
concentration of PB1.3 was most effective at preventing P-selectin- 
dependent  leukocyte rolling in  vivo  (27).  To  study  a  role  for 
L-selectin, animals  were  treated with an anti-L-selectm antibody, 
HRL-3 (31) (Upjohn Company, Kalamazoo, MI) at i  mg/kg i.v. 
at 20 rain (32). An isotype-matched control antibody had no ef- 
fect on leukocyte rolling in the rat mesentery (27). Additionally, 
we examined the role of a selectin-binding polysaccharide, fucoi- 
din (25 mg/kg; Sigma Chemical Co., St. Louis, MO), that targets 
L- and P-selectin (1, 33, 34). To confirm that this concentration 
of fucoidin prevented selectin-dependent rolling, untreated  (no 
M. butyricum immunization) animals were also given the carbohy- 
drate moiety. This regimen has previously been shown to inhibit 
>85% ofroUing interactions under baseline conditions (I, 25, 26). 
M.  butyricum-immunized  animals responded only partially to 
anti-selectin therapy, suggesting the possibility that other rolling 
pathways exist in vivo. To date, in addition to selectins, only the 
el4-integrin has been  proposed to  support leukocyte rolling on 
endothelium  (20).  Therefore,  in another series  of experiments, 
immunized animals received an antibody directed against the ci  4- 
integrin chain (TA-2, 4 mg/kg). This antibody has been shown 
to block lymphocyte adhesion to  cytokine-stimulated rat endo- 
thelial cells in vitro (14, 35), and attenuate lymphocyte accumula- 
tion in rat dermal sites during delayed-type hypersensitivity reac- 
tions, without causing leukocytopenia or lymphocyte aggregation 
(13).  Evidence that TA-2 binds the ot4-integrin has been docu- 
mented extensively elsewhere (35).  To ensure that this antibody 
did not affect leukocyte trafficking nonspecificaUy, untreated ani- 
mals received identical doses of TA-2. To determine whether the 
132-integrin  was  contributing  to  ~x4-dependent  adhesion,  a  rat 
anti-CD18 antibody (WT-3, 2 mg/kg) was given to animals (36, 
37). At this concentration, WT-3 inhibits leukocyte adhesion in- 
duced by N-formyl-met-leu-phe (fMLP) (37). 
Since cx4-integrins are not found on circulating neutrophils (8), 
it was likely that a nonneutrophil leukocyte population was inter- 
acting with endothelium in M. butyricum-immunized  animals. To 
confirm this possibility, animals were given an anti-PMN serum 
(0.1  ml/rat;  Accurate Chemical  &  Scientific Corp.,  Westbury, 
NY) that depletes circulating PMN populations, without affecting 
other leukocyte subpopulations. To confirm that the cx4-depen- 
dent population ofleukocytes was distinct from the PMNs, some 
animals were treated with the anti-PMN serum and then received 
the anti-oq antibody after depletion of PMNs.  In a final experi- 
ment, animals were treated with fucoidin, and once a new base- 
line flux was achieved, the animals received the anti-e~  4 antibody. 
Systemic blood samples were  obtained at the beginning and 
end of each experiment for determination of total cell counts and 
population distributions. 
Statistical Analysis.  All values are reported as means -  SEM. 
The data within groups were compared using a paired Student's 
t test with Bonferroni corrections for multiple comparisons where 
appropriate. An unpaired Student's t test was used to compare be- 
tween groups. Statistical significance was set at P <0.05. 
Results 
Hemodynamic  measurements,  including red blood cell 
velocity, calculated venula~ shear stress,  and shear rates  of 
control and M.  butyricum-immunized  rats are summarized 
in Table  1,  These  parameters remained stable throughout 
the 60-rain protocol in both control and immunized rats. 
Additionally, venular diameters did not change throughout 
the 60-rain protocols (data not shown).  The red blood cell 
velocities  and  shear  measurements  did  not  differ  signifi- 
candy between any of the groups.  Immunized animals did 
not  show  any macroscopic signs of disease until day 8,  at 
which point tissue necrosis was observed around the injec- 
tion site. By day 12, some joint swelling was apparent and 
increased by day 20.  Immunized animals also exhibited re- 
duced weight gain compared with controls (data not shown). 
Despite the lack of any clinical evidence for disease 4  d 
after immunization, the flux of rolling leukocytes through 
the  mesenteric  venules was  profoundly elevated from  less 
than  30  ceils/rain in  untreated  animals to  more  than  150 
ceils/min in M.  butyricum-treated  animals  (Fig.  1 A). This 
value varied between ~120  and 230  cells/min with differ- 
ent lots of M.  butyricum  and mineral oil adjuvant, The in- 
creased flux of rolling leukocytes was maintained at elevated 
Table 1.  Hemodynamic Parameters of Untreated and M. butyricum-immunized animals 
Day 4 
Parameter  Control (n =  7)  (n =  10) 
M. butyricum immunized 
Day 8  Day 12  Day 20 
(n  =  4)  (n =  4)  (n =  6) 
RBC velocity (re_m/s)  2.4 •  0.3  2.1  •  0.3  2.1  •  0.3  2.0 +  0.2  1.9 •  0.3 
Shear stress (dyn/cm  2)  9.6 •  1.4  7.0 •  1.1  8.0 •  1.9  7.0 •  1.0  6.8 •  1.1 
Shear rate (r  383  •  57  281  +  44  320 •  74  279  +  40  270 •  45 
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Figure 1.  Leukocyte (A) rolling flux, (B) adhesion, and (C) emigra- 
tion in mesenteric postcapillary venules of untreated (CON, n = 7) and 
M. butyricum-immunized (4-20 d) animals. Leukocyte trafficking in im- 
munized animals was examined 4 (n -  10), 8 (n = 4), 12 (n = 4), or 20 
(n = 6) d after treatment with heat-killed M. butyricum in Freund's min- 
eral oil adjuvant. Values represent the average leukocyte flux and adhesion 
levels  until  at least  20  d  after  inmmnization.  M.  butyricum 
treatment appears to be a very potent inducer of leukocyte 
rolling inasmuch  as  we  have  not  observed  more  than  70 
rolling  cells/min  in  the  rat  mesenteric  vasculature  under 
control or stimulated (leukotrienes,  histanfine, oxidants, mast 
cell activation) conditions (27, 28, 38, 39). Fig. 1 B also dem- 
onstrates  that  4,  8,  12,  and  20  d  after M.  butyricum  treat- 
ment,  a significant number of rolling cells  stopped and ad- 
hered firmly to the venular endothelium relative to very few 
adherent  cells  (~5  cell/100-txm-length  venule)  in untreated 
animals.  The peak number of adherent  cells  was observed 
at  day  4,  reaching  an  average  of 18  cells/100-txm-length 
venule.  This  is  comparable  to  values  previously  observed 
after acute  exposure  of the  mesentery to proinflammatory 
molecules such as PAF or LTB  4 (40, 41).  It is interesting to 
note that very few of the adherent cells  emigrated into the 
surrounding interstitium in immunized animals at any time 
point during the 20-d period after treatment  (Fig.  1 C). At 
day  12,  a  slight  increase  in  emigration  was  observed  (4-5 
cells),  nevertheless,  this was of much lower magnitude than 
the 20-40 cells that transmigrated after administration of in- 
flammatory mediators such as platelet  activating factor, leu- 
kotriene B4, or fMLP (40, 41). 
Table 2 summarizes circulating leukocyte numbers in con- 
trol and M.  butyricum-immunized  animals. In untreated an- 
imals, "30  and 70% of circulating leukocytes were PMNs 
and  PBMCs,  respectively.  4  d  after  immunization  with 
M.  butyricum,  the  total  number  of circulating  leukocytes 
was increased  by 53%.  The  increase  could be  entirely  at- 
tributed  to  PMNs  inasmuch  as  there  was  a  four-fold  in- 
crease in these cells and a reduction in the number of circu- 
lating mononuclear cells.  This reduction in PBMCs may be 
related  to  an  increased  marginated  pool  inasmuch  as  the 
anti-0t 4 mAb did increase circulating mononuclear cell num- 
bers  (data  not shown). Differential analysis revealed a change 
in the distribution of cells  in M.  butyricum-imnmnized  ani- 
mals;  ~70% of the leukocytes were PMNs whereas PBMCs 
accounted for 30% of the population. This distribution was 
maintained 20 d after treatment. 
As leukocyte and hemodynamic parameters reached new 
baseline  levels  by  4  d  after  immunization,  and  remained 
constant for the next 20 d, we chose to focus the remainder 
of this  study on the  adhesive  mechanisms underlying leu- 
kocyte trafficking 4 d after immunization with M. butyricum. 
Fig.  2  is  a  photomicrograph  illustrating  the  high  level  of 
leukocyte rolling and  adhesion  observed in M.  butyricum- 
immunized animals after exteriorization of the rat mesenteric 
microcirculation (/t) compared with the few rolling or adher- 
ing leukocytes observed in mesenteric venules of untreated 
control preparations  (B).  Fig.  3  shows that  over a 60-min 
experiment, the mesenteric microcirculation in M. buwicum- 
treated  (4  d)  rats  supported  significantly elevated  numbers 
observed during the first 60 n'fin after exteriorization of the mesentery on 
the indicated day after immunization. Leukocyte emigration reflects the 
initial emigration observed upon exteriorization of the mesentery on the 
indicated day after immunization. (*) P <'0.05 relative to untreated group. 
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Total count  % PMN  PMN count  % PBMC  PBMC count 
(￿  10S/m])  distribution  (X 10s/m])  distribution  (￿  10S/m]) 
Control (n =  7)  71.7 -4- 4.8  28.2 +  1.8  20.2 -+ 1.4  71.8 +  1.8  51.5 +  3.4 
M. butyricum 
Day 4 (n =  10)  110.3 •  7.6*  71.8 +  3.3*  79.2 +  5.5*  28.2 +  3.3*  31.1 +_ 2.1" 
Day 20 (n =  6)  146.1 +- 8.6*  67.0 +  1.7"  97.9 +  5.8*  33.0 +  1.7"  48.2 +  2.8 
*P <0.05 with respect to control. 
of rolling (A), and adherent leukocytes (B), but no increase 
in the number of emigrated leukocytes (C), relative to un- 
treated control animals. Elevated leukocyte rolling was sta- 
ble  over 60  min in immunized animals, whereas elevated 
leukocyte adhesion increased further by 15  rain and then 
remained stable for the remainder of the experiment. These 
observations are important inasmuch as stability in leuko- 
cyte kinetics by 15 rain permitted the use of each animal as 
its  own  control in  subsequent  experiments where  the  ef- 
fects of various antiadhesive molecules were examined. 
Fig.  4  summarizes the role of selectins in the leukocyte 
rolling observed in M.  butyricum-treated  animals. An anti- 
P-selectin  antibody  (PB1.3)  reduced  leukocyte rolling by 
<25%,  whereas an anti-L-selectin antibody (HRL-3) was 
more  effective, reducing  leukocyte  rolling by 43%  (from 
150 to 85 cells/rain). The inset illustrates the pattern of in- 
hibition of leukocyte rolling; after steady elevated levels of 
rolling (time 0 and 15 min), HRL-3 was administered (20 
rain)  and the number of rolling cells remaining was deter- 
mined at 30  and 60 rain of the protocol. The data reveal 
that  a  rapid  reduction  in  leukocyte rolling flux  could be 
achieved with  HRL-3, and that this  reduction was main- 
tained for the subsequent 30 rain. This pattern was consis- 
tent for each of the anti-selectin therapies used. Fucoidin, a 
P- and L-selectin binding carbohydrate, reduced leukocyte 
rolling by 52% (Fig. 4). It is important to note that the same 
concentration of fucoidin reduced leukocyte rolling in un- 
treated animals by >90%, to a flux of 3 cells/min (Table 3). 
In immunized animals treated with fucoidin,  70 cells/rain 
still  rolled through the mesenteric venules, suggesting that 
4  d  of exposure  to  heat-killed  M.  butyricum evokes new 
pathways of leukocyte rolling in vivo. 
Qualitatively, after fucoidin administration,  there was a 
noticeable decrease in the size of the rolling cells, suggesting 
that the remaining rolling leukocytes were a distinct popu- 
lation of white cells. To test this hypothesis, immunized ani- 
mals were treated with an anti-PMN serum. Fig. 5 demon- 
strates that the anti-PMN serum reduced leukocyte rolling 
to the same degree as fucoidin ("o50%)  and again revealed a 
greater  proportion  of smaller  cells  rolling.  Confirmation 
that the anti-PMN serum was only affecting PMNs is illus- 
trated in Table 4. The anti-PMN serum reduced the num- 
ber of circulating PMNs  by "-'88%, without  affecting the 
PBMC  population.  Higher doses of the  anti-PMN  serum 
caused reductions in systemic blood pressure and blood flow 
and therefore were not used (data not shown). In untreated 
animals,  the  safiae regimen  reduced  leukocyte  rolling  by 
"~  to less than 10 cells/rain (Table 3). 
Based on recent in vitro work by numerous investigators, 
there is growing evidence that the oq-integrin can support 
non-PMN (i.e., PBMC)  rolling and adhesion (18-21).  In- 
deed, administration of an anti-or  4 antibody (TA-2) to M. 
butyricum-inununized animals caused a 50% reduction in the 
flux of rolling leukocytes within minutes of administration, 
and this rolling continued to wane until at 60 min >65% of 
the leukocyte rolling was eliminated (Fig. 6). These data il- 
lustrate for the first time the importance of the ~4-integrin 
as an adhesive mechanism that can mediate the rolling of 
endogenous leukocytes along the venular endothelium in a 
chronic inflammatory model. This observation again differed 
significantly from untreated animals in which baseline leu- 
kocyte rolling was unaffected by the anti-or  4 mAb (Table 3). 
These data raise the possibility that PMNs use primarily 
selectins to roll in postcapillary venules, whereas PBMCs roll 
primarily via the  et4-integrin  in  vivo.  To provide further 
evidence that there were two distinct populations  of cells 
rolling via two  distinct  mechanisms,  tandem  therapy was 
administered to some animals.  Fig.  7  demonstrates a  57% 
reduction  in leukocyte rolling with  the  anti-PMN  serum 
(given at 20  rain),  which  was inhibited  further to  >88% 
when the anti-or 4 mAb was given at 65 rain. Although the 
data do not add up to exactly 100%, an explanation for this 
may be related to the incomplete (~88%)  removal of cir- 
culating PMNs with the antiserum.  Tandem therapy with 
fucoidin plus TA-2 (Fig.  8) eliminated leukocyte rolling in 
M.  butyricum-treated  animals.  After  fucoidin  treatment, 
~-'70 cells/rain rolled past a fixed point in the venule, how- 
ever  subsequent  addition  of the  anti-oq  antibody  com- 
pletely eliminated leukocyte rolling.  These data demonstrate 
that some leukocytes can roll in vivo via a selectin-inde- 
pendent,  e~4-dependent  mechanism,  and  that  selectins  are 
not obligatory to maintain rolling. 
In addition to rolling, it is now well appreciated that the 
eq-integrin can support finn adhesion in vitro (18-21). Fig. 
9 demonstrates that the increased number of adherent leu- 
kocytes  observed in  M.  butyricum-immunized  animals  was 
eliminated by the anti-or  4 mAb, consistent with previous in 
vitro data  (35).  Administration of the anti-PMN serum or 
1999  Johnston et al. Figure 2.  Representative photomicrographs of mesenteric preparations in (A) M. butyricum-immunized  (4 d after treatment), and (B) untreated ani- 
mals.  In the immunized animal, >150 cells rolled or adhered to the venular wall.  11 leukocytes can be seen rolling through the venule from the untreated 
preparation. Playback analysis (frame-by-frame) is necessary to quantitate the number of  rolling and adherent leukocytes within a 100-1xm-length vessel seg- 
ment. Leukocytic influx is observed in venules (v) but not arterioles (a). ￿ 
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Leukocyte (A) rolling flux,  (/3) adhesion,  and (C) emigration 
in mesenteric postcapillary  venules of untreated (open circles, n =  7) and 
M. butyricum-irmnunized  (dosed circles, n =  10) animals 4 d after treatment. 
Leukocyte rolling flux in M. butyricum-immunized  animals remained sta- 
ble over the 60-rain protocol, and was elevated relative to untreated ani- 
mals. Leukocyte adhesion was elevated relative  to untreated animals and 
L-selectin  mAb (HRL-3,  1 mg/kg; n  =  5),  or an anti-P-selectin mAb 
(PB1.3, 2 mg/kg; n =  4) 20 min into a 60-min protocol. (Inset) Adminis- 
tration protocol used for all treatments.  In  this case,  administration of 
HRL-3 at 20 min caused a rapid and stable reduction in rolling flux, al- 
lowing the treatment time points to be compared with the initial baseline 
time points within each animal.  The other treatments produced similar 
response  patterns (not shown).  (')  P  <0.05  relative  to time 0  rain.  (I") 
P <0.05 relative to immunized animals not receiving therapy. 
an  anti-CD18  inAb  (WT-3)  at  20  rain  had  no  effect  on 
leukocyte  adhesion in this chronic model  (Fig.  9).  Leuko- 
cyte adhesion was not affected by any of the three different 
anti-selectin treatments (data not shown). 
Leukocyte  rolling  has  recently  been  demonstrated  to 
consist of two  distinct events  (42),  the first step,  the initial 
attachment  or tethering of leukocytes  to  the  endothelium 
and the second step, the actual rolling event. Both L-selec- 
tin and the oq-integrin have been postulated to play a critical 
role  in leukocyte  tethering in vitro  (20,  42).  Fig.  10  dem- 
onstrates  a  role  for  L-selectin,  but  not  the  oq-integrin  in 
leukocyte  tethering  in  vivo.  Treatment  with  an  anti- 
L-selectin mAb reduced the number of tethering interactions 
increased further by 15 min before remaining stable. Emigration increased 
slightly in both groups during the 60-rain experiments. (*) P <0.05 rela- 
tive to time 0 rain. (t) P <0.05 relative to untreated group. 
2001  Johnston et al. Table 3.  Leukocyte Rolling Flux in Control Animals Receiving 
Antiadhesion  Molecule Therapy 
Table 4.  Cell Counts in M. butyricum-immunized  Animals 
Treated with Anti-PMN Serum (n  =  7) 
Flux of rolling 
leukocytes 
(cells/min) 
Control (n =  7) 
plus fucoidin (25 mg/kg; n =  4) 
plus anti-PMN serum (0.1 M/rat; n =  5) 
plus anti-c~  4 mAb (4 rng/kg; n =  3) 
34.5 +  7.5 
3.0 _  1.0" 
9.8 _+ 2.4* 
33.0 --+ 4.5 
Total count  PMN count  PBMC count 
(X lOS/m])  (X lOS/ml)  (X lOS/ml) 
Day 4 M. butyricum  102.9  +  9.0  72.9  _4_- 6.4  30.0  _  2.6 
plus anti-PMN serum 
(0.1 ml/rat)  40.6 _+ 3.8*  8.4 _+ 0.8*  32.2  __+ 3.0 
*P <0.05 with respect to day 4 M. butyricum treatment. 
* P <0.05 with respect to control. 
by '~50%. Treatment with the anti-oq mAb however,  did 
not cause a significant reduction in the number of tethering 
interactions. After the administration of the anfi-a  4 mAb, a 
very distinct pattern of leukocyte-endothelial cell interac- 
tions  was  observed.  A  certain  proportion  of leukocytes 
made  very brief (<1  s)  contacts  with  the  vessel wall but 
then detached instead of rolling, giving the appearance of a 
glancing, stop-and-go interaction. Both PMNs and PBMCs 
tethered in the postcapillary venules inasmuch as the anti- 
PMN  serum reduced the number of tethering interactions 
by only 60% (Fig. 10). 
The velocity of rolling leukocytes was unaffected by any 
of the treatments administered in this study (Fig.  11), sug- 
gesting that PMNs and PBMCs roll at similar velocities de- 
spite  the  differences  in  adhesive  mechanisms  employed. 
Additionally, the behavior of PBMCs  was  very similar to 
that previously described for PMNs.  Cells always appeared 
to roll along the endothelium before adhering firmly. 
Discussion 
In this manuscript we describe for the first time, the im- 
portance  of the  oq-integrin as  an  adhesion  molecule  that 
supports both  PBMC  rolling and  adhesion under  physio- 
logic shear stress (4-16 dyn/cm  2) in a model of chronic in- 
flammation. The study also documents that the eq-integrin 
can support leukocyte rolling independent of selectins, in- 
asmuch  as fucoidin did not inhibit the eq-integrin-depen- 
dent  leukocyte  rolling.  These  observations  question  the 
obligatory requirement  for selectins in  the  recruitment  of 
leukocytes to sites of inflammation. A  similar conclusion is 
reached  with  respect  to  adhesion  inasmuch  as  an  anti-oq 
antibody entirely prevented the  adhesion of cells without 
the necessity of further reinforcement from other adhesion 
molecules such as the [32-integnns.  Clearly unlike selectins 
or other integrins, the oq-integrin was sufficiently versatile 
to  independently support  two  distinguishable steps of the 
multi-step recruitment paradigm i.e., rolling and adhesion. 
Finally, our study demonstrates that the level ofoq-integrin 
expression present on endogenous cells is sufficient to sup- 
port PBMC rolling and adhesion at physiological shear rates, 
but was not sufficient to support the initial tethering inter- 
action in vivo. 
It is  well  established that  virtually all  of the  leukocyte 
rolling observed under baseline or acute inflammatory con- 
ditions can be eliminated by and-L-selectin or anti-P-selectin 
antibodies or by the selectin-binding polysaccharide fucoi- 
din  (1,  27,  43).  In  contrast,  a  very significant number  of 
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Leukocyte rolling flux in M.  butyricum-irnrnunized animals 
treated at 20 min with an anti-PMN serum (0.1 ml/rat) followed at 65 
min with an anti-or  4 mAb (TA-2, 4 Ixg/kg; n = 3). (*) P <0.05 relative to 
time 0 rain. 
rolling cells in postcapillary venules of M.  butyricum-immu- 
nized animals were  resistant to  these  therapies and depen- 
dent entirely on the oq-integrin. These ot4-dependent roll- 
ing  cells  were  also  insensitive  to  an  anti-PMN  serum, 
whereas  >85%  of all circulating PMNs  and ~75%  of leu- 
kocyte rolling could be eliminated by this antiserum under 
baseline  conditions.  These  data  suggest  that  the  cx4-inte- 
grin-dependent  rolling  cells  were  not  PMNs  but  more 
likely PBMCs. 
Presently, it remains technically impossible to more spe- 
cifically identify the type of PBMC  that was rolling via cx  4- 
integrins in vivo.  Circulating monocytes,  eosinophils, and 
T  cells (but not neutrophits)  all are known  to  express cq- 
integrins (35, 44, 45), with memory T  cells expressing higher 
levels than naive CD4 +  T  cells (35).  However,  it does not 
appear that oq-integrins necessarily support identical behav- 
ior in each  of these  cell populations. Luscinskas et al.  (21) 
reported  that  monocytes  that  express  both  L-selectin and 
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Figure  9.  Leukocyte  adhesion  in M.  butyricum-immunized  animals 
treated at 20 rain with an anti-PMN serum (0.1 ml/rat; n =  7), an anti- 
CD18 mAb (WT-3, 2 mg/kg; n =  4), or an anti-~  4 mAb (TA-2, 4 mg/ 
kg; n =  4). (Inset) Administration protocol used for all treatments. In this 
case, administration of TA-2 at 20 n'fin caused a rapid reduction in leuko- 
cyte adhesion. The treatment time points were compared with the initial 
baseline time points within each animal. The other treatments did not af- 
fect leukocyte adhesion, d-) P <0.05 relative to immunized animals not 
receiving therapy. 
0[4~ 1 only used the former to tether and roll in vitro, whereas 
O~4~ 1  was  used  primarily  for  adhesion.  Sriramarao  et  al. 
(46) demonstrated  that  human  eosinophils rolled in rabbit 
IL-l~timulated  mesenteric  venules,  mAbs  against  the 
oL4-integrin and L-selectin each inhibited rolling by ~'-,50%, 
suggesting  a  contribution  of both  adhesion  molecules  to 
eosinophil rolling. However, in these IL-l-treated venules, 
adhesion was  not observed,  making it impossible to  estab- 
lish whether the cx4-integrin was important in the adhesion 
of these  leukocytes to postcapillary venules. In flow cham- 
bers, T  cells were  observed to roll and adhere to VCAM-1 
transfectants,  and  both  processes  were  inhibited by  anti- 
bodies  to  the  eq-  or  131-integrins  (18,  20).  In  contrast, 
IL-l-treated  endothelium supported  T  cell  tethering  and 
rolling that  was  independent of the  &4-integrin (19).  The 
distinctions observed in these studies may reflect differences 
in the density or avidity of the cq-integrin as well as differ- 
ences in the expression of ligands for the cx4-integrins, and 
make  it  difficult  to  extend  these  data  to  the  role  of the 
oq-integrin in chronically inflamed postcapillary venules. In 
our study, we demonstrate that the oq-integrin can support 
both rolling and subsequent adhesion of PBMCs, in a manner 
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Figure  10.  Leukocyte  tethering in M.  butyricum-immunized animals 
treated with an anti-~  4 mAb (TA-2, 4 mg/kg; n = 4), an anti-L-selectin 
mAb (HRL-3, 1 mg/kg; n = 4), or an anti-PMN serum (0.1 ml/rat; n = 
4). Tethering was measured as the number of leukocyte interactions initi- 
ated within a 100-1xm venule segment over a l-rain period. (*) P <0.05 
relative to inmmnized animals not receiving  treatment. 
qualitatively  and  quantitatively  identical  to selectin-depen- 
dent rolling and CD18-dependent  adhesion previously re- 
ported for neutrophils.  Clearly, the ~x4-integrin could con- 
ceivably play the role of both selectins and integrins in the 
recruitment  of PBMCs  into  inflamed  microvessels  during 
the pathogenesis of chronic inflammatory disease. 
The anti-oq antibody was also able  to eliminate  PBMC 
adhesion,  whereas  the  anti-selectin  regimens  and  an  anti- 
CD18  antibody  (WT-3)  failed to reduce leukocyte adhe- 
sion.  Clearly,  the  adhesive  mechanisms  in  M.  butyricum- 
treated  animals  are  distinct  from  the  acute  inflammatory 
condition  wherein  we  and  others  have  documented  that 
essentially all  of the leukocyte adhesion was CD18 depen- 
dent  (7,  28,  37,  47).  To  our  knowledge,  this  is  the  first 
documentation that the e~4-integrin can support both roll- 
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Figure 11.  Leukocyte  rolling velocity in venules of  day 4 M. butyricum- 
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din (FUC, 25 mg/kg; n = 8), an anti-PMN serum (0.1 ml/rat; n = 7), or 
an anti-~4 mAb (TA-2, 4 mg/kg; n = 4). No statistically significant dif- 
ferences were found between different groups. 
ing and firm adhesion of endogenous leukocytes at physio- 
logic shear in postcapillary venules in vivo. A  provocative 
finding in this study is that in postcapillary venules 4 d after 
M.  butyricum  immunization,  there was a very selective sig- 
nal for PBMCs to adhere  despite  very similar  numbers of 
rolling PMNs  and  PBMCs.  Whether this  reflects  the  par- 
ticular  type  of endothelial  ligand  involved  (abundance  of 
VCAM-1 versus lack of ICAM-1), the release  of a specific 
chemotactic agent, or whether it reflects the overproduction 
of some endogenous antiadhesive molecule (prostacyclin or 
nitric  oxide)  specific  for  neutrophils  remains  unknown. 
However this observation clearly demonstrates the exquis- 
ite  control  of the  vasculature  in  recruiting  PBMCs  versus 
PMNs in chronic inflammatory processes. 
Tethering  of leukocytes to the  endothelium  and rolling 
of leukocytes  along  the  length  of the  endothelium  have 
recently been shown to be separable steps that involve dis- 
tinct  ligands.  For  example,  Lawrence  et  al.  (42)  demon- 
strated  that  L-selectin is required  for efficient  tethering  to 
purified E-selectin, but is not required for subsequent rolling 
on this ligand. The cx4-integrin  has also been postulated to be 
an important tethering molecule; T  lymphocytes, as well as 
a  K562  erythroleukemia  cell  line  transfected  with  o~4131, 
tethered, rolled, and adhered to recombinant VCAM-1 un- 
der flow conditions in vitro (20). Herein, we examined the 
tethering phenomenon in an in vivo model  of inflamma- 
tion by counting the number of tethering interactions (new 
attachments)  that  transpired  in  25-50-1~m-diameter  vessels 
with  shear  forces ranging from 4  to  16  dyn/cm  2.  An  anti- 
L-selectin antibody significandy reduced the number of initial 
contacts that leukocytes made with the endothelium within a 
specific region under observation, demonstrating for the first 
time that L-selectin is an important tethering molecule under 
physiologic shear in postcapillary venules.  This observation 
also suggests that tethering is not due simply to the displace- 
ment ofleukocytes towards the vessel wall by red blood cells 
but is mediated specifically by adhesive mechanisms. 
It is  interesting  to  note  that  when  an  anti-0q  antibody 
was administered  to M.  butyricum-immunized  animals,  the 
rolling was  selectively  attenuated  whereas  the  initial  brief 
interactions  between  cells  and  endothelium  could  still  be 
observed.  These  attachments  were  manifested  as  glancing 
stop-and-go interactions where the obvious impairment was 
the inability of tethered cells to engage in prolonged rolling 
interactions.  At first glance, these data do not appear to be 
entirely consistent with the in vitro data. However, it should 
be noted that tethering to isolated VCAM-1  via 0/.4[~  1  was 
observed at 0.73 dyn/cm  2, but not at higher shear (20).  In 
the same study, when the wall shear stress was increased to 
1.8, 3.6,  or 7.3 dyn/cm  2 the cells  that had tethered at low 
shear were able to sustain a rolling interaction,  but tether- 
ing itself did not occur under these physiologic shear con- 
ditions.  This supports our observation that the oL4-integrin, 
expressed  at  levels  that  could support  PBMC  rolling,  did 
not support tethering in vivo. In this respect, it is notewor- 
thy to point out that Jones  et al.  (19)  observed c~4-depen- 
dent  tethering  and  rolling of PBMCs  on VCAM-1  trans- 
fectants  at  1.9  dyn/cm  2,  but  could  not  prevent  tethering 
2004  The ~x4-Integrin Supports Leukocyte-Endothelial Interactions In Vivo and rolling with the same anti-~x 4 antibody on cytokine stim- 
ulated endothelium. This latter observation raises the possi- 
bility that  tethering  could occur via cq-integrin  in vessels 
expressing higher levels of VCAM-1,  or in smaller vessels 
at lower shear. 
There are a few other noteworthy characteristics regard- 
ing PBMC  recruitment  in postcapillary venules.  Removal 
of rolling PMNs with the anti-PMN serum permitted us to 
examine  the  rolling  behavior  of PBMCs  in  postcapillary 
venules.  Although  the  cells  appeared  smaller,  they  rolled 
with  the  same  velocity as  PMNs.  This  was  evident  from 
treatment  with  the  anti-cq  mAb  which  likely  eliminated 
the rolling PBMCs; the remaining cells also rolled with the 
same velocity. These data suggest that for similar rolling ve- 
locities to be observed, the on/offrate and perhaps the ten- 
sile strength of rolling interactions (48) mediated by the se- 
lectins  and  the  et4-integrin  were  of similar  duration  and 
magnitude.  Finally,  the  sequence  of events  for each  sub- 
population ofleukocytes was similar i.e., regardless of treat- 
ment,  the  remaining  cells rolled before adhering firmly in 
postcapiUary venules.  This observation is somewhat differ- 
ent from the description of leukocytes colliding and adher- 
ing within the high endothelial venules of the Peyer's patch 
without first rolling (49). Clearly in the current study of in- 
flamed postcapiUary venules,  the  cascade of events leading 
to firm attachment was similar for PMNs and PBMCs de- 
spite entirely different molecular mechanisms of adhesion. 
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